Efficacy of a novel cytotoxic polybisphosphonate for treatment of bone metastasis in castration-resistant prostate cancer (CRPC).

被引：0
|
作者：
Nilsson, Sten
Lindberg, Henriette
Thellenberg-Karlsson, Camilla
Nyman, Claes
Marquez, Marcela
Lennartsson, Lena
Blom, Rene
Castellanos, Enrique
Holmberg, Anders R.
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Herlev Hosp, Copenhagen, Denmark
[3] Umea Univ, Umea, Sweden
[4] Karolinska Inst, Stockholm, Sweden
[5] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[6] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16065
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of a novel cytotoxic polybisphosphonate for treatment of bone metastasis in castration-resistant prostate cancer (CRPC).
    Nilsson, Sten
    Lindberg, Henriette
    Thellenberg-Karlsson, Camilla
    Nyman, Claes
    Marquez, Marcela
    Lennartsson, Lena
    Blom, Rene
    Castellanos, Enrique
    Holmberg, Anders R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] Treatment of Bone Metastasis in Prostate Cancer: Efficacy of a Novel Polybisphosphonate
    Daubine, Florence
    Le Bot, Ronan
    Marquez, Marcela
    Nilsson, Sten
    Schroder, Torbjorn
    Holmberg, Anders R.
    ANTICANCER RESEARCH, 2011, 31 (12) : 4141 - 4145
  • [3] Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
    Thellenberg-Karlsson, Camilla
    Nyman, Claes
    Nilsson, Sten
    Blom, Rene
    Marquez, Marcela
    Castellanos, Enrique
    Holmberg, Anders R.
    ANTICANCER RESEARCH, 2016, 36 (12) : 6499 - 6504
  • [4] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    UROLOGE, 2014, 53 (03): : 391 - 399
  • [5] Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)
    Lee, Daniel J.
    Cha, Eugene K.
    Dubin, Justin M.
    Beltran, Himisha
    Chromecki, Thomas F.
    Fajkovic, Harun
    Scherr, Douglas S.
    Tagawa, Scott T.
    Shariat, Shahrokh F.
    BJU INTERNATIONAL, 2012, 109 (07) : 968 - +
  • [6] Kaiso as a novel therapeutic target in castration-resistant prostate cancer (CRPC)
    Lin, Hui-Xian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Addai, Benjamin Adu
    Grizzle, William E.
    Yates, Clayton
    CANCER RESEARCH, 2019, 79 (13)
  • [7] The efficacy of metastasis-directed radiation therapy (MDRT) for oligometastatic castration-resistant prostate cancer (CRPC)
    Nagahara, Akira
    Kanaki, Tomohiro
    Yamamoto, Akinaru
    Yamamoto, Yoshiyuki
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Konishi, Koji
    Teshima, Teruki
    Nishimura, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer
    Lee, Patrick
    Aragon-Ching, Jeanny B.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (10) : 1040 - 1045
  • [9] Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)
    Mitsogiannis, Iraklis C.
    Skolarikos, Andreas
    Deliveliotis, Charalambos
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (03) : 493 - 501
  • [10] Treatment patterns by oncologists and urologists for castration-resistant prostate cancer (CRPC)
    Alemayehu, B.
    Nitz, N. M. Engel-
    Nathan, F. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345